According to a new report by GBI Research, the number of cardiac surgeries will fall in the U.S. due to a growing preference for non-surgical options. The U.S. is the biggest market for cardiovascular surgery devices, due to factors such as an aging population and increasing numbers of patients with heart disease. However, the increasing adoption of alternative, minimally invasive treatment procedures seem to be reducing the number of operations.
In particular, the report points to the popularity of percutaneous coronary intervention (PCI) and other minimally invasive treatements that stem from patient fears of post-surgery complications, financial struggles and a shortage of cardiac surgeons. In 2010 the U.S. was responsible for $688 million spent on cardiovascular surgery devices, accounting for 38 percent of the global market. This is forecast to decline at a rate of 1.6 percent annually, reaching a market value of $616.1m in 2017. The decline of its biggest customer means that, globally, the cardiovascular surgery devices market is forecast to decline to $1.6 billion by 2017.
The perfusion disposables market was the largest category in the global cardiovascular surgery devices market in 2010, accounting for a 79 percent share, but even this high-demand surgical device is projected to drop in value by $100 million over the next five years.